Clinical Trial Update: Diurnal Variation in Hypertensive Stroke Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating diurnal variation in hypertensive stroke patients conducted by Hanmi Pharmaceutical Company Limited. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stroke

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Hypertension, Stroke | Phase 4 | Status: COMPLETED